Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideaki Iwasaki is active.

Publication


Featured researches published by Hideaki Iwasaki.


Bioscience, Biotechnology, and Biochemistry | 2017

Dammarane-type triterpene extracts of Panax notoginseng root ameliorates hyperglycemia and insulin sensitivity by enhancing glucose uptake in skeletal muscle

Kumiko Kitamura; Yusuke Takamura; Taku Iwamoto; Mitsuru Nomura; Hideaki Iwasaki; Motoyasu Ohdera; Michiaki Murakoshi; Keikichi Sugiyama; Kazuki Matsuyama; Yasuko Manabe; Nobuharu Fujii; Tohru Fushiki

Skeletal muscle is an important organ for controlling the development of type 2 diabetes. We discovered Panax notoginseng roots as a candidate to improve hyperglycemia through in vitro muscle cells screening test. Saponins are considered as the active ingredients of ginseng. However, in the body, saponins are converted to dammarane-type triterpenes, which may account for the anti-hyperglycemic activity. We developed a method for producing a dammarane-type triterpene extract (DTE) from Panax notoginseng roots and investigated the extract’s potential anti-hyperglycemic activity. We found that DTE had stronger suppressive activity on blood glucose levels than the saponin extract (SE) did in KK-Ay mice. Additionally, DTE improved oral glucose tolerance, insulin sensitivity, glucose uptake, and Akt phosphorylation in skeletal muscle. These results suggest that DTE is a promising agent for controlling hyperglycemia by enhancing glucose uptake in skeletal muscle. Graphical abstract DTM improved hyperglycemia.


Applied Microbiology and Biotechnology | 2018

Characterization of oil-producing yeast Lipomyces starkeyi on glycerol carbon source based on metabolomics and 13C-labeling

Yuki Maruyama; Yoshihiro Toya; Hiroshi Kurokawa; Yuka Fukano; Atsushi Sato; Hiroyasu Umemura; Kaoru Yamada; Hideaki Iwasaki; Norio Tobori; Hiroshi Shimizu

Lipomyces starkeyi is an oil-producing yeast that can produce triacylglycerol (TAG) from glycerol as a carbon source. The TAG was mainly produced after nitrogen depletion alongside reduced cell proliferation. To obtain clues for enhancing the TAG production, cell metabolism during the TAG-producing phase was characterized by metabolomics with 13C labeling. The turnover analysis showed that the time constants of intermediates from glycerol to pyruvate (Pyr) were large, whereas those of tricarboxylic acid (TCA) cycle intermediates were much smaller than that of Pyr. Surprisingly, the time constants of intermediates in gluconeogenesis and the pentose phosphate (PP) pathway were large, suggesting that a large amount of the uptaken glycerol was metabolized via the PP pathway. To synthesize fatty acids that make up TAG from acetyl-CoA (AcCoA), 14 molecules of nicotinamide adenine dinucleotide phosphate (NADPH) per C16 fatty acid molecule are required. Because the oxidative PP pathway generates NADPH, this pathway would contribute to supply NADPH for fatty acid synthesis. To confirm that the oxidative PP pathway can supply the NADPH required for TAG production, flux analysis was conducted based on the measured specific rates and mass balances. Flux analysis revealed that the NADPH necessary for TAG production was supplied by metabolizing 48.2% of the uptaken glycerol through gluconeogenesis and the PP pathway. This result was consistent with the result of the 13C-labeling experiment. Furthermore, comparison of the actual flux distribution with the ideal flux distribution for TAG production suggested that it is necessary to flow more dihydroxyacetonephosphate (DHAP) through gluconeogenesis to improve TAG yield.


Archive | 2010

Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages

Hiroaki Kambayashi; Kumiko Kitamura; Hideaki Iwasaki


Archive | 2012

GLUCOSE METABOLISM-IMPROVING AGENT AND GLUCOSE METABOLISM-IMPROVING COMPOSITION

Hideaki Iwasaki; Hiroaki Kambayashi; Mitsuru Nomura; Naho Suzuki; Kumiko Kitamura


Archive | 2009

Hyperlipidemia-ameliorating agent

Hideaki Iwasaki; Hiroaki Kamibayashi; Kumiko Kitamura; 博明 上林; 久美子 北村; 英明 岩崎


Archive | 2010

COMPOSITION CONTAINING PROTOPANAXATRIOL AND PROTOPANAXADIOL

Hideaki Iwasaki; Mitsuru Nomura; Naho Suzuki; Hiroaki Kambayashi; Kumiko Kitamura


Archive | 2009

Composition including at least either one of protopanaxatriol and protopanaxadiol

Hideaki Iwasaki; Hiroaki Kamibayashi; Kumiko Kitamura; Mitsuru Nomura; Naho Suzuki; 博明 上林; 久美子 北村; 英明 岩崎; 充 野村; 苗穂 鈴木


Archive | 2012

COMPOSITION WITH STABILIZED SAPOGENIN, METHOD FOR PRODUCING THE SAME, AND FOOD AND DRINK

Mitsuru Nomura; 充 野村; Hideaki Iwasaki; 英明 岩崎


Archive | 2012

Panaxadiol-containing composition

Yusuke Takamura; Mitsuru Nomura; Hideaki Iwasaki


Archive | 2012

Composition contenant du panaxadiol

Yusuke Takamura; Mitsuru Nomura; Hideaki Iwasaki

Collaboration


Dive into the Hideaki Iwasaki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge